Clinical Trials Directory

Trials / Conditions / Ewing Sarcoma of Bone

Ewing Sarcoma of Bone

12 registered clinical trials studyying Ewing Sarcoma of Bone — 3 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingRegorafenib in Patients With Refractory Primary Bone Tumors
NCT05395741
Institute of Mother and Child, Warsaw, PolandPhase 1 / Phase 2
WithdrawnPhase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
NCT05116800
Brown UniversityPhase 2
RecruitingComparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
NCT05033288
Mayo Clinic—
CompletedPerioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirem
NCT05024253
Children's Cancer Hospital Egypt 57357Phase 3
RecruitingObservational Study on Skeletal Ewing's Sarcoma
NCT04845893
Italian Sarcoma Group—
CompletedChemotherapy-induced Necrosis in Ewing Sarcoma
NCT03968471
Istituto Ortopedico Rizzoli—
RecruitingLiquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
NCT06068075
Dana-Farber Cancer InstituteN/A
WithdrawnWhole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue i
NCT01795430
City of Hope Medical CenterN/A
Completed18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and
NCT01825902
Mayo ClinicEARLY_Phase 1
CompletedTwo Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sar
NCT00618813
Children's Oncology GroupN/A
CompletedEvaluating Dactinomycin and Vincristine in Young Patients With Cancer
NCT00674193
Children's Oncology Group—
CompletedVincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating You
NCT00516295
National Cancer Institute (NCI)Phase 2